✦ LIBER ✦

MP29-14 TARGETING HYALURONIC ACID FAMILY BIOMARKERS FOR TREATMENT OF RENAL CELL CARCINOMA

✍ Scribed by Ortiz, Nicolas; Garcia-Roig, Michael; Yates, Travis; Manoharan, Murugesan; Lokeshwar, Vinata

Book ID: 122304646
Publisher: Lippincott Williams and Wilkins
Year: 2014
Tongue: English
Weight: 399 KB
Volume: 191
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2014.02.756

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

606 PROGNOSTIC SIGNIFICANCE OF HYALURONI

606 PROGNOSTIC SIGNIFICANCE OF HYALURONIC ACID FAMILY FOR METASTATIC RENAL CELL CARCINOMA

✍ Garcia-Roig, Michael; Ortiz, Nicholas; Yates, Travis; Soloway, Mark; Bird, Vince 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 59 KB

T-cell therapy targeting minor histocomp

T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma

✍ Warren, E.H.; Tykodi, S.S.; Murata, M.; Sandmaier, B.M.; Storb, R.; Jaffee, E.; 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 86 KB

Interferon-α-2a with or without 13-cis r

Interferon-α-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma : Results of a randomized Phase II study (European Organization for Research and Treatment of Cancer Study 30951)

✍ Sophie D. Fosså; Gerald H. J. Mickisch; Pieter H. M. De Mulder; Simon Horenblas; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Background: In patients with metastatic renal cell carcinoma (mrcc), interferon-alpha (ifn) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. in 1995, preclinical and clinical data indicated an improvement of these results if ifn was combined with 13-cis retin

Randomized phase II/III trial of interfe

Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951): Aass N, De Mulder PHM, Mickisch GHJ, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ, Department of Clinical Cancer Research, The Norwegian Radium Hospital, Oslo, Norway

✍ Robert Flanigan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB